Emerging Complications in Infectious Diseases

Infectious diseases are caused by pathogenic bacteria, viruses, fungi, parasites or nematodes.  Most of these organisms’ live on/ in our skins and body and are mostly harmless, but they do turn pathogenic when the immune system is compromised, hence termed as opportunistic microorganisms. Infectious diseases that are passed from person to person are communicable diseases and have the capacity to cause an outbreak. Diseases that are caused by animals or animal bites are called zoonotic diseases while others are developed by consumption of contaminated food or water.

International Congress on Bacteriology and Infectious Diseases, May 16-18, 2016, San Antonio, Texas, USA; Euro-Global Microbiology Conference, July 14-15, 2016, Cologne, Germany; International Conference on Water Microbiology & Novel Technologies- July 18-20, 2016 Chicago, USA; 5th Global Microbiologists Annual meeting -August 15-17, 2016 Portland, USA; 2nd world congress on Beneficial Microbe -September 23-25, 2016 Phoenix, USA; Microbial Physiology conference- September 29-30, 2016; London, UK; Infectious Diseases Conference- Oct 3-5, 2016 Vancouver, Canada; International Conference on Medical Parasitology 2016 , October 17-19, 2016, Houston, USA; Clinical Microbiology Conference- October 24-26, 2016 Rome, Italy;  Applied Microbiology, November 10-12, 2016 Istanbul, Turkey.

Communicable diseases are whose incidents that have grown in numbers for the past thirty five years and will increase within the near future. Rising infections account for a minimum of twelve-tone system of all human pathogens. EIDs are caused by new known species or strains (e.g. SARS, AIDS) which will have evolved from an identified infection (e.g. influenza) or unfold to a replacement population (e.g. West Nile River virus) or space undergoing ecologic transformation (e.g. Lyme disease), or reemerging infections, like drug resistant TB. 
The global microbiology market is valued at $6,727.29 million in 2014 and is expected to grow at a CAGR of 13.03% between 2014 and 2019. Increasing disease burden of infectious diseases and increased funding for healthcare expenditure are the important growth drivers for this market during the forecast period. The pharmaceuticals application segment accounted for the largest share of the microbiology market in 2014, while the food application segment is expected grow at the highest CAGR between 2014 and 2019 in the global microbiology market.


  • Types of Infectious Diseases
  • Microbial Pathogenesis and Virulence
  • Infectious Diseases in Animals
  • Diagnosis of Infectious Diseases
  • Treatment for Infectious Diseases
  • HIV,Ebola,Tuberculosis,Hepatitis
  • Infectious Diseases Prevention & Cure
  • Increasing Resistance of pathogens against anti-microbials

Related Conference of Emerging Complications in Infectious Diseases

February 20-21, 2019 |

8th Annual Summit on Microbiology

San Francisco, California, USA
March 18-19, 2019

3rd International Conference on Microbial Ecology & Eco Systems

Chicago, Illinois, USA
(10 Plenary Forums 2 days 1 event)
March 04-06, 2019

9th Global Summit on Microbiology & Infectious Diseases

Prague, Czech Republic
May 01-02, 2019

3rd International Conference on Medical and Clinical Microbiology

| ANA Crowne Plaza | Kyoto, Japan
May 20-21, 2019

4th International Conference on Applied Microbiology and Beneficial Microbes

| Radisson Hotel Narita | Tokyo , Japan
June 24-25, 2019

48th World Congress on Microbiology

Moscow, Russia
July 01-02, 2019

11th International Virology Summit

Valencia, spain
July 26-27, 2019

World Yeast Congress

Vancouver | Canada
October 23-24, 2019

2nd Global Experts Meeting on Chronic Diseases

| Radisson Hotel Narita | Tokyo, Japan
24-25 October, 2019

6th World Congress and Expo on Applied Microbiology

Rome, Italy
December 12-13, 2019

23rd World Congress on Biotechnology

Auckland, New Zealand

Emerging Complications in Infectious Diseases Conference Speakers